218
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Design, synthesis, biological evaluation and molecular dynamics simulation studies of (R)-5-methylthiazolidin-4-One derivatives as megakaryocyte protein tyrosine phosphatase 2 (PTP-MEG2) inhibitors for the treatment of type 2 diabetes

ORCID Icon, , , &
Pages 3156-3165 | Received 10 Jul 2019, Accepted 29 Jul 2019, Published online: 22 Aug 2019
 

Abstract

PTP-MEG2 plays a significant role in insulin production and is able to enhance insulin signaling and improve insulin sensitivity. So, PTP-MEG2 inhibitors are closely associated with type 2 diabetes therapy. A series of novel (R)-5-methylthiazolidin-4-one derivatives were designed and synthesized, and their PTP-MEG2 inhibitory activities (IC50) were determined. Among the desired compounds, 1h shares the highest inhibitory activity (IC50 = 1.34 μM) against PTP-MEG2. Additionally, various post-dynamic analyses confirmed that when compound 1h bound to the PTP-MEG2, the protein conformations became unstable and the function of the pTyr recognition loop (Asn331-Cys338) would be disturbed. And thus, the ideal conformations needed for the catalytic activity was difficult to be maintained. In brief, these might be how the compound 1h worked. Furthermore, we also found that the key residues Arg332 would play a critical role in disturbing the residue interactions.

Abbreviations
DCCM=

dynamic cross-correlation mapping

DMF=

N,N-dimethylformamide

DSSP=

definition of secondary structure of proteins

FOXO=

forkhead transcription factors

MD=

molecular dynamics

PCA=

principal component analysis

PDB=

protein data bank

PTKs=

protein tyrosine kinases

PTPs=

protein tyrosine phosphatases

PTP-MEG2=

megakaryocyte protein tyrosine phosphatase 2

RIN=

residue interaction network

RING=

Residue Interaction Network Generator

RMSD=

root means square deviation

RMSF=

root mean square fluctuation

Communicated by Ramaswamy H. Sarma

Disclosure statement

The authors declare that they have no conflict of interest.

Additional information

Funding

This work was supported by the National Natural Science Foundation of China (91773569), Natural Science Foundation of Tianjin (16JCZDJC32500 and 18JCQNJC13700) and Science & Technology Development Fund of Tianjin Education Commission for Higher Education (2017KJ229). Furthermore, we are grateful for Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.